BNP/CALL/BRISTOL-MYERS SQUIBB/65/0.1/17.01.25

BNP/CALL/BRISTOL-MYERS SQUIBB/65/0.1/17.01.25 Stock

DE000PE896C5

Market Closed - Deutsche Boerse AG 03:50:28 2024-06-07 pm EDT
0.012 ^EUR	+9.09%

Current month	+20.00%
1 month	+20.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart BNP/CALL/BRISTOL-MYERS SQUIBB/65/0.1/17.01.25

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Geron shares surge after U.S. FDA approves blood disorder drug	Jun. 07	RE
I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers	Jun. 05	MT
Bristol Myers Squibb Announces Opdivo Plus Yervoy Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma	Jun. 05	AQ
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers	Jun. 05	CI

More news

Quotes 5-day view

Date	Price	Change
24-06-07	0.012	+9.09%
24-06-06	0.011	0.00%
24-06-05	0.011	-8.33%
24-06-04	0.012	0.00%
24-06-03	0.012	+20.00%

Delayed Quote Deutsche Boerse AG

Last update June 07, 2024 at 03:50 pm EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	BNP Paribas
WKN	PE896C
ISIN	DE000PE896C5
Date issued	2023-02-16
Strike	65 $
Maturity	2025-01-17 (223 Days)
Parity	10 : 1
Emission price	1.27 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.31 €
Lowest since issue	0.001 €
Spread	0.079 €
Spread %	86.81%

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.48 USD

Average target price

53.19 USD

Spread / Average Target

+28.24%

Consensus